These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21448934)

  • 1. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.
    Ciernik IF; Niemierko A; Harmon DC; Kobayashi W; Chen YL; Yock TI; Ebb DH; Choy E; Raskin KA; Liebsch N; Hornicek FJ; Delaney TF
    Cancer; 2011 Oct; 117(19):4522-30. PubMed ID: 21448934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy.
    Wenkel E; Thornton AF; Finkelstein D; Adams J; Lyons S; De La Monte S; Ojeman RG; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1363-70. PubMed ID: 11121635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning.
    Hug EB; Fitzek MM; Liebsch NJ; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):467-76. PubMed ID: 7852108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis.
    Demizu Y; Jin D; Sulaiman NS; Nagano F; Terashima K; Tokumaru S; Akagi T; Fujii O; Daimon T; Sasaki R; Fuwa N; Okimoto T
    Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):367-374. PubMed ID: 28463156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy for local control of osteosarcoma.
    DeLaney TF; Park L; Goldberg SI; Hug EB; Liebsch NJ; Munzenrider JE; Suit HD
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):492-8. PubMed ID: 15667972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of radiotherapy in oseosarcoma.
    Schwarz R; Bruland O; Cassoni A; Schomberg P; Bielack S
    Cancer Treat Res; 2009; 152():147-64. PubMed ID: 20213389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy in the treatment of primary osteosarcoma--a single center experience.
    Oertel S; Blattmann C; Rieken S; Jensen A; Combs SE; Huber PE; Bischof M; Kulozik A; Debus J; Schulz-Ertner D
    Tumori; 2010; 96(4):582-8. PubMed ID: 20968138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents.
    Meazza C; Luksch R; Daolio P; Podda M; Luzzati A; Gronchi A; Parafioriti A; Gandola L; Collini P; Ferrari A; Casanova M; Terenziani M; Spreafico F; Polastri D; Biassoni V; Schiavello E; Pecori E; Massimino M
    Med Oncol; 2014 Apr; 31(4):875. PubMed ID: 24557586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiation therapy in resected high-grade localized skeletal osteosarcomas treated with neoadjuvant chemotherapy: Long-term outcomes.
    Sole CV; Calvo FA; Alvarez E; Cambeiro M; Cuervo M; San Julian M; Sole S; Martinez-Monge R; Sierrasesumaga L
    Radiother Oncol; 2016 Apr; 119(1):30-4. PubMed ID: 26970678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
    Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
    Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.
    DeLaney TF; Liebsch NJ; Pedlow FX; Adams J; Dean S; Yeap BY; McManus P; Rosenberg AE; Nielsen GP; Harmon DC; Spiro IJ; Raskin KA; Suit HD; Yoon SS; Hornicek FJ
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):732-9. PubMed ID: 19095372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial.
    Ferguson WS; Harris MB; Goorin AM; Gebhardt MC; Link MP; Shochat SJ; Siegal GP; Devidas M; Grier HE
    J Pediatr Hematol Oncol; 2001; 23(6):340-8. PubMed ID: 11563767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
    Blattmann C; Oertel S; Schulz-Ertner D; Rieken S; Haufe S; Ewerbeck V; Unterberg A; Karapanagiotou-Schenkel I; Combs SE; Nikoghosyan A; Bischof M; Jäkel O; Huber P; Kulozik AE; Debus J
    BMC Cancer; 2010 Mar; 10():96. PubMed ID: 20226028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton radiotherapy in management of pediatric base of skull tumors.
    Hug EB; Sweeney RA; Nurre PM; Holloway KC; Slater JD; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1017-24. PubMed ID: 11958897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy.
    Shibamoto Y; Ohshio G; Hosotani R; Nishimura Y; Manabe T; Imamura M; Abe M
    Br J Cancer; 1997; 76(11):1474-9. PubMed ID: 9400944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and gemcitabine-docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma.
    Lee JA; Paik EK; Seo J; Kim DH; Lim JS; Yoo JY; Kim MS
    Jpn J Clin Oncol; 2016 Feb; 46(2):138-43. PubMed ID: 26685322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.